TY -的T1 -肺癌生长缓慢的埃米尔ging entity: from screening to clinical management JF - European Respiratory Journal JO - Eur Respir J SP - 1706 LP - 1722 DO - 10.1183/09031936.00186212 VL - 42 IS - 6 AU - Infante, Maurizio AU - Berghmans, Thierry AU - Heuvelmans, Marjolein A. AU - Hillerdal, Gunnar AU - Oudkerk, Matthijs Y1 - 2013/12/01 UR - //www.qdcxjkg.com/content/42/6/1706.abstract N2 - The current paradigm is that untreated lung cancer is invariably and rapidly fatal, therefore the medical community normally dismisses the idea that a patient could live with such a disease for years without any therapy. Yet evidence from lung cancer screening research and from recent clinical series suggests that, although rarely recognised in routine practice, slow-growing lung cancers do exist and are more common than previously thought. Here, current evidence is reviewed and clinical cases are illustrated to show that slow-growing lung cancer is a real clinical entity, and the reasons why management protocols developed in the screening setting may also be useful in clinical practice are discussed. Features suggesting that a lung cancer may be slow-growing are described and appraised, areas of uncertainty are examined, modern management options for early-stage disease are evaluated and the influence that all this knowledge might have on our clinical decision-making is weighed. Further research directed at developing appropriate guidelines for these peculiar but increasingly common patients is warranted. The increasingly common incidence of slow-growing lung cancer and its influence on clinical decision-making is discussed http://ow.ly/oZ6c2 ER -